English
Dr. Tinku Takia | Medical Oncology in Patiala | Manipal Hospitals

Dr. Tinku Takia

Consultant - Medical Oncology

Book Appointment

Subscribe to our blogs

Dr. Tinku Takia | Medical Oncology in Patiala | Manipal Hospitals
Reviewed by

Dr. Tinku Takia

Consultant - Medical Oncology

Manipal Hospitals, Patiala

How Personalised Medicine is Changing Cancer Treatment

Reviewed by:

Dr. Tinku Takia

Posted On: Dec 30, 2025
blogs read 6 Min Read
Cancer treatment with personalised medicine

In the evolving landscape of cancer care, a revolutionary approach is emerging that promises more effective, less toxic treatments: Personalised Medicine. No longer is cancer treatment a one-size-fits-all solution; instead, it is becoming as unique as each patient it aims to heal. At Manipal Hospitals, we are at the forefront of integrating these advanced strategies, offering hope and tailored solutions to those battling cancer through personalised cancer treatment.

 

Understanding Personalised Medicine in Cancer Treatment

Personalised medicine, often called precision oncology, tailors cancer treatment to an individual's unique genetic, molecular, and environmental characteristics and overall health. Unlike traditional approaches that apply standard therapies to broad cancer types, personalised medicine delves deeper, recognising that even cancers of the same organ can behave differently due to distinct biological makeups, demanding a more nuanced approach to cancer treatment.

  • Targeted Approach: It focuses on specific abnormalities within cancer cells, aiming to stop their growth without harming healthy cells, making the cancer treatment highly precise.

  • Individualised Care: Treatment plans are designed for the individual, considering their genetic profile, lifestyle, and the specific characteristics of their tumour, ensuring optimal cancer treatment.

  • Advanced Diagnostics: Utilises sophisticated tests to identify unique biomarkers and genetic mutations present in a patient’s cancer, guiding the selection of the most effective cancer treatment.

Common Symptoms Addressed by Personalised Cancer Treatment

Personalised medicine effectively manages key cancer symptoms like persistent fatigue, unexplained weight loss, lumps or swelling, chronic pain, night sweats, and persistent cough. For breast cancer symptoms, it targets hormone-driven pain and lumps; for lung cancer symptoms, it addresses cough and breathlessness through precise therapies.

Key Technologies Driving Personalised Cancer Treatment

Significant advancements in diagnostic technologies and therapeutic options largely drive the advent of personalised medicine in oncology. These technologies are fundamentally reshaping how we approach cancer treatment, moving towards unprecedented precision and efficacy.

Technology

Description

Impact on Cancer Treatment

Genomic Profiling & Sequencing

Analyses tumour DNA for specific mutations, genefusions, or alterations driving cancer growth.


Crucial for selecting therapies that target precise anomalies, revolutionising cancer treatment.

Biomarker Testing

Identifies specific molecules indicating disease presence, severity, or treatment response.


Predicts patient response to immunotherapies and other targeted cancer treatments.

Liquid Biopsies


Non-invasive blood test detecting circulating tumour DNA (ctDNA) released by tumour cells.


Monitors treatment effectiveness, detects early recurrence, and guides therapy decisions for flexible cancer treatment.

Immunotherapy

Harnesses the body’s immune system to fight cancer, often guided by personalised diagnostics.

Biomarkers predict which patients respond best, enhancing this form of advanced cancer treatment.

The Transformative Benefits for Patients Undergoing Personalised Cancer Treatment

The shift towards personalised medicine is bringing about profound benefits for cancer patients, enhancing the effectiveness and experience of cancer treatment.

  • Improved Efficacy: By targeting the specific drivers of cancer, personalised treatments often lead to higher response rates and better outcomes. Studies show that patients receiving targeted therapies based on genomic profiling can experience a 30-50% improvement in progression-free survival compared to conventional cancer treatments.

  • Reduced Side Effects: Because these treatments are designed to attack cancer cells more precisely, they often spare healthy tissues, leading to fewer and less severe side effects, significantly enhancing the patient’s quality of life during cancer treatment.

  • Early Detection and Monitoring: Technologies like liquid biopsies enable earlier detection of recurrence and continuous monitoring of treatment response, allowing for timely adjustments to therapy, optimising ongoing cancer treatment.

  • Optimised Treatment Selection: Eliminates the trial-and-error approach, ensuring patients receive the most effective cancer treatment from the outset, saving valuable time and resources. For example, for certain lung cancers, personalised approaches have doubled the two-year survival rate to over 80% in specific patient groups.

Personalised Treatments for Common Cancer Symptoms

For symptoms like colon cancer symptoms (bloody stools, abdominal pain), personalised therapies target KRAS mutations; stomach cancer symptoms (indigestion, nausea) benefit from HER2-targeted drugs, reducing bloating and vomiting effectively.

Types of Cancers Benefiting from Personalised Cancer Treatment

Personalised medicine is making a significant impact across a wide range of cancers, transforming the landscape of cancer treatment.

Cancer Type

Key Personalisation Factors

Impact on Treatment & Specifics

Lung Cancer


EGFR, ALK, ROS1 mutations


Guides highly effective targeted therapies, improving outcomes for this specific cancer treatment.

Breast Cancer

HER2 status, hormone receptor expression, genomic signatures

Dictates precise treatment choices and chemotherapy regimens, optimising breast cancer treatment.

Colorectal Cancer

KRAS, NRAS, BRAF mutations


Critical for determining eligibility for certain targeted drugs, enhancing colon cancer treatment efficacy.

Stomach Cancer


HER2 amplification, PD-L1 expression, MSI status

Allows for targeted therapies and immunotherapies, offering advanced options for stomach cancer treatment.

Melanoma

BRAF mutations


Commonly targeted, leading to dramatically improved outcomes for many patients in their melanoma treatment.

Leukemias & Lymphomas


Specific chromosomal translocations, genetic markers (e.g., Philadelphia chromosome)


Guides highly effective targeted therapies, crucial for advanced blood cancer treatment.

Pancreatic Cancer

BRCA mutations, MSI-High tumours


Identifies candidates for PARP inhibitors or immunotherapy, expanding pancreatic cancer treatment options.

The Role of Manipal Hospitals in Personalised Cancer Treatment

At Manipal Hospitals, we are committed to providing cutting-edge cancer treatment. Our approach to personalised medicine is comprehensive and patient-centric, focusing on delivering the best possible outcomes for all our patients.

  • State-of-the-Art Diagnostics: We utilise advanced genomic sequencing and molecular diagnostic platforms to accurately profile individual tumours, guiding personalised cancer treatment strategies.

  • Multidisciplinary Team: Our expert oncologists, geneticists, pathologists, and radiologists collaborate to interpret complex genomic data and formulate highly individualised cancer treatment plans.

  • Access to Innovative Therapies: We ensure patients have access to the latest targeted therapies and immunotherapies, often participating in clinical trials for emerging cancer treatments. This includes specialised approaches for blood cancer treatment, colon cancer treatment, and stomach cancer treatment.

  • Compassionate Support: Beyond treatment, we offer comprehensive support services, including genetic counselling, nutritional guidance, and psychological support, to ensure holistic patient well-being during their cancer treatment journey.

FAQ's

Typically, genomic test results can take anywhere from 2 to 4 weeks, depending on the complexity of the tests ordered. Your doctor will discuss the expected timeline with you for your personalised cancer treatment plan.

While personalised medicine is expanding rapidly, its applicability currently varies by cancer type and stage. It is most established for cancers with known actionable mutations, like lung, breast, colorectal (including colon cancer treatment), and certain blood cancer treatment approaches. Your oncologist will determine if it’s an option for your specific cancer treatment needs.

While the initial diagnostic tests can be costly, personalised treatments can ultimately be more cost-effective by avoiding ineffective therapies and reducing the need for managing severe side effects. Insurance coverage for these advanced cancer treatments is also improving.

Personalised medicine aims to treat existing cancer more effectively and can reduce the risk of recurrence by targeting specific cancer-driving mechanisms. However, it does not guarantee prevention of recurrence, and ongoing monitoring is crucial even after successful cancer treatment.

Yes, while generally milder than traditional chemotherapy, personalised treatments can still have side effects. These are typically specific to the targeted pathway and vary widely. Your care team will explain potential side effects for your specific cancer treatment therapy.

Share this article on:

Subscribe to our blogs

Thank You Image

Thank you for subscribing to our blogs.
You will be notified when we upload a new blog

You’re on Our Indian Website

Visit the Global site for International patient services